ArticleNPJ vaccines2026
Influenza vaccine-specific CD4
Article in NPJ vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Immune defenses decline with age, increasing susceptibility to influenza. Vaccination remains the most effective strategy to prevent severe disease and death, but its efficacy is reduced in older adults, particularly against influenza A(H3N2). The mechanisms underlying this age-related decline in vaccine-specific antibody responses remain unclear. We investigated the magnitude and quality of influenza-specific T-cell responses following quadrivalent inactivated influenza vaccination in adults aged under (n = 100) or over (n = 120) 65 years. Frequencies of T cells specific to influenza A (H1N1, H3N2) and influenza B (Victoria, Yamagata) strains were measured before and after vaccination. Polyfunctionality of vaccine-induced CD4⁺ and CD8⁺ T cells and immune ageing markers were assessed in a subset of responders (n = 34). Older adults exhibited significantly reduced H3N2-specific CD4⁺ T-cell frequencies (P = 0.01) and polyfunctionality (P = 0.04), which correlated with lower H3N2 hemagglutination inhibition antibody titers (r = 0.42, P = 0.008). Cytomegalovirus seropositivity was associated with diminished influenza-specific CD8⁺ T-cell responses in the older age group (P = 0.01). These findings demonstrate quantitative and qualitative deficiencies in influenza-specific memory T cells with ageing, which may contribute to impaired humoral responses, particularly against H3N2. This highlights the need for vaccines that more effectively enhance cellular immunity in older adults, potentially through improved H3N2 antigen design or alternative vaccine platforms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.